The autosomal dominant spinocerebellar ataxias (SCAs) are a diverse group of neurological disorders anchored by the phenotypes of motor incoordination and cerebellar atrophy. Disease heterogeneity is appreciated through varying comorbidities: dysarthria, dysphagia, oculomotor and/or retinal abnormalities, motor neuron pathology, epilepsy, cognitive impairment, autonomic dysfunction, and psychiatric manifestations. Our study focuses on SCA13, which is caused by several allelic variants in the voltage-gated potassium channel KCNC3 (Kv3.3 
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Introduction
Patients with dominant cerebellar ataxias display adult-onset, progressive motor incoordination, and cerebellar atrophy [1] [2] [3] [4] [5] . Previously, we reported causation of the autosomal dominant disorder SCA13 by mutations in the voltage-gated potassium channel gene, KCNC3 (MIM: 176264, Kv3.3) [6] [7] [8] . This tetrameric-delayed rectifier channel facilitates rapid firing of action potentials in the cerebellum, hippocampus, and brainstem [9] [10] [11] [12] . Two allelic forms of SCA13 [7, 8, 13] , p.Arg420His (KCNC3
R420H
) and p.Phe448Leu (KCNC3
F448L
) [7] , have been described. Their phenotypes are distinct in that KCNC3 R420H results in a slowly progressive, adult-onset ataxia, whereas KCNC3 F448L presents in childhood with delayed motor milestones. Screening of ataxia DNA repositories identified a third mutation, g.10693G>A; p.
Arg423His (KCNC3

R423H
), displaying early-onset SCA13 [14] [15] [16] . We report a detailed phenotypic description of this allelic form in a child who presented at age 7 months and in three additional multigeneration kindreds with multiple affected persons. Features include infantile onset with delayed gross and/or fine motor milestones, tremor, seizures, cognitive impairment, gait and/or appendicular ataxia, and dysarthria. Magnetic resonance imaging (MRI) confirms marked cerebellar hypoplasia as early as 10 months of age. Longitudinal follow-up demonstrates non-progressive cerebellar hypoplasia, with lifetime improvement in motor and cognitive function. Therefore, SCA13
R423H may be considered a congenital ataxia causing a fixed deficit, that is, it is partially overcome by normal development, with eventual accomplishment of motor and cognitive milestones. We provide supportive evidence for neurodevelopmental onset through a Drosophila model. Biophysical studies and experiments on cellular localization also address channel activity and protein trafficking. Our studies also speak to a cellular basis for dominant inheritance and congenital cerebellar hypoplasia.
Materials and methods
Human genotyping and MRI
Patient DNA was isolated from blood (QIAamp Blood kit) or saliva (Oragene) following written informed consent and approval from the Institutional Review Board of the University of Florida, Gainesville, Florida (IRB project . Written informed consent for minors was obtained from the next of kin. This study was performed in accordance with the Declaration of Helsinki. All patient-derived sequencing was performed with specific primers (S1 Table) at the DNA Sequencing Core, University of Florida. Midline sagittal T1-weighted MR images of patients were collected at multiple institutions.
Plasmid constructs
The human KCNC3 WT cDNA was provided by Dr. James L. Rae (Mayo Foundation, Rochester, Minnesota). Individual mutants (KCNC3
R420H
, KCNC3
R423H
, or KCNC3
F448L
) were generated by polymerase chain reaction (PCR) with QuikChange Mutagenesis (Agilent Technologies) (S1 Table) . The cDNA encoding human KCNC3 WT and KCNC3 R423H was amplified with primers appropriate for translation in flies, subcloned into the fly expression vector pUAST, then injected into yw embryos (Rainbow Transgenic Flies). All constructs were verified by sequencing. PCRamplified human KCNC3 WT cDNA and all mutant coding sequences with an enhanced Kozak site were subcloned into modified green fluorescent protein (GFP) and red fluorescent protein (RFP) vectors, pcDNA3-Clover and pcDNA3-mRuby2 (Addgene #40259, #40260, provided by Michael Lin) [17] , or Cerulean3-N1 [18] (Addgene #54742, provided by Michael Davidson, S1 
Drosophila genetics and imaging
Fly stocks were obtained from the Bloomington Drosophila Stock Center (flystocks.bio.indiana.edu, S2 Table) . All crosses were at 25˚C unless indicated otherwise. Adult wings (n = 6) and frozen adult eyes (n = 7) were processed and imaged, as previously described [19] .
Cell culture and transfection
Flp-In-CHO (Chinese hamster ovary, Thermo Fisher Scientific) and human glioblastoma U87 cells (ATCC, HTB-14) were cultured in Ham's F-12 or DMEM (Dulbecco's modified Eagle's medium) (Corning), respectively, with 10% fetal bovine serum (FBS), 25mM glucose, 4mM glutamine, and pen/strep (penicillin-streptomycin) at 37˚C, 5% CO 2 . Transient transfections were carried out using Lipofectamine LTX with Plus reagent (Life Technologies). Total DNA was kept constant by adding control pcDNA3.1 plasmid.
Immunoblot analysis
Protein from individual 2-day-old flies or CHO or U87 cells was analyzed, as previously described, [19] with the modification of resolution with 3-8% Tris-acetate gels (Life Technologies). Co-immunoprecipitation experiments were performed with Dynabeads Protein G (Thermo Fisher Scientific) using α-EGFR (Abcam) for binding and α-EGFR (EMD Millipore) and α-KCNC3 (Alomone Labs) for detection. Full-length blots are presented in S1 
Electrophysiology
CHO cells were grown in Iscove's modified Dulbecco's medium (Invitrogen), with 10% FBS, 100 units/ml pen/strep, 5% HT supplement (Thermo Fisher Scientific) in 5% CO 2 at 37˚C. Seeded cells were transfected 24h later using Lipofectamine reagent (Invitrogen) with the mRuby2-or Clover-tagged KCNC3 WT 
Immunofluorescence
Eye-imaginal discs of third instar fly larvae were immunostained using a standard protocol [20] with bovine serum albumin (BSA) for blocking. 
Statistical analysis
Statistical analysis with SEM values are presented using an unpaired, two-tailed t-test for significance ( ÃÃÃ , p<0.001). All analyses were performed using Microsoft Excel and GraphPad Prism.
Results
Causative inheritance, phenotype and MR imaging associated with the KCNC3 R423H allele
Four multigenerational pedigrees segregating KCNC3 R423H provided definitive genetic proof of causation through complete fidelity in allele segregation of sequenced, affected, and unaffected family members (Fig 1A-1D ). Case 423-2 illustrates de novo inheritance in patient II-2. Midline T1-weighted sagittal MR images demonstrate pronounced cerebellar hypoplasia. A 35-year-old control (Fig 1E) is compared to a 42-year-old affected family member (423-1, II-3, Fig 1F) . T1-weighted MR images of a 10-month-old (423-1, III-1, Fig 1G; inset; age-matched control) and a 21-month-old (423-2, II-2, Fig 1H) 
Expression of human KCNC3 R423H in Drosophila melanogaster wing and eye
Developmental consequences of R423H expression were examined in strains of Drosophila melanogaster expressing human KCNC3
WT and KCNC3 R423H controlled by the yeast UAS/ Gal4 expression system [25] . All driver and responder fly strains are summarized in S2 Table. Expression of KCNC3 WT and KCNC3 R423H in transgenic flies was verified by immunoblot (Fig 2A) from individual 2-day-old flies controlled by the ubiquitous daughterless (da)-Gal4 driver [26] . We expressed LacZ, KCNC3 WT , or KCNC3 R423H in the developing wing (Fig 2B-2G ), along the anteroposterior boundaries extending to the anterior compartment using the decapentaplegic (dpp)-Gal4 driver. Gal4/KCNC3 R423H expression caused complete loss of the anterior cross vein (ACV) and partial loss of vein L3 (Fig 2G) . The flies were kept at 29˚C to achieve maximal Gal4-transgene expression with minimal effects on viability and fertility [27] . KCNC3 R423H expression in the developing wing pouch, using the A9-Gal4 driver [28] , resulted in severely altered wing morphology and vein patterning (Fig 2H-2J ).
To test the mutant allele in a developing neuronal lineage, we utilized the eye-specific driver gmr-Gal4 [29] for expression throughout eye development. KCNC3 R423H expression displayed marked eye dysmorphology and a profound reduction in size (Fig 2M) , disrupted ommatidial organization, fused ommatidia, and malformed eye bristles (Fig 2P and 2S ) compared to those of a normal eye phenotype in KCNC3 WT and a control LacZ (Fig 2K, 2L , 2N, 2O, 2Q and 2R).
Sagittal sections of the KCNC3 WT eyes illustrate regular arrangement of each lens at the apex of the elongated ommatidium, in contrast with the disrupted pattern observed in the KCNC3 R423H eyes (S2A and S2B Fig) . In addition to the adult eye, we stained the eye imaginal discs from wandering third instar larvae for the pan-neuronal marker elav [30] . 
KCNC3 R423H intracellular location and biophysics
We recently reported that the KCNC3 R420H allele [7, 8, 32] displayed altered post-translational modifications with aberrant retention in the Golgi [19] . CHO cells, with no detectable endogenous KCNC3, transiently transfected with human KCNC3 WT (Fig 3A) , show normal plasma membrane localization by immunofluorescence. In contrast, cells expressing KCNC3
R423H
( Fig 3C; compare to KCNC3 R420H in Fig 3B) , demonstrate aberrant trafficking with strong perinuclear staining analogous to the KCNC3 R420H allele [19] . As illustrated with other representative cells (Fig 3B and 3C insets) aberrant trafficking is consistently observed with both mutants. To corroborate the aberrant trafficking, we then generated C-terminal Clover-tagged vectors [17] harboring. Confocal microscopy illustrates normal plasma membrane localization (Fig 3D) for KCNC3 WT , in contrast to absent plasma membrane localization and clear perinuclear retention for each mutant (Fig 3E and 3F ). This aberrant trafficking is found in all cells from multiple independent transfection experiments. For further comparison, we also expressed the Clover-tagged SCA13 mutation from a French pedigree, KCNC3
F448L
, which displays normal plasma membrane trafficking (Fig 3G) , although associated with altered biophysical properties [7] .
To demonstrate that protein overexpression was not responsible for aberrant localization, we show that over about an 8- , or β-galactosidase (LacZ)) under control of the ubiquitous da-Gal4 driver (full-length blot shown in S1 Fig). Pathological mechanisms associated with a congenital non-progressive SCA13 causative mutation 
To determine the intracellular localization of the mutant channel, we used fluorescently tagged markers of endoplasmic reticulum (ER), Golgi, and intracellular vesicles. Sigma receptor 1 (SIGMAR1) is a highly conserved, transmembrane chaperone protein located in the ER membrane [33] . On co-expression of the cyan fluorescent protein (CFP) tagged SIGMAR1 (SIGMAR1 CFP ) with KCNC3 R423H-mRuby2 (Fig 3H-3J) , we observed no co-localization, which rules out aberrant retention in the ER. JMY is linked to cytosolic actin assembly and acts as a DNA damage-induced transcriptional co-activator of p53 [34, 35] . Recently, Schlüter et al.
[36] also demonstrated JMY's role in vesicular trafficking at the trans-Golgi network through actin-dependent elongation and/or tubulation of anterograde vesicles. Co-expression of JMY GFP with KCNC3 R423H-mRuby2 resulted in co-localization (Fig 3K-3M ) in vesicular structures, implying the retention of KCNC3 R423H in trafficking vesicles. PI4K2A, a membranebound phosphatidylinositol-4 kinase, localizes to the trans-Golgi network (TGN) and early endosomes [37, 38] and is responsible for phosphorylation of phosphatidylinositol (PI) to phosphatidylinositol 4-phosphate (PI4P), a critical lipid in endocytosis, Golgi function, protein sorting, and membrane trafficking [39] . Co-expression of KCNC3 R423H-mRuby2 with PI4K2A GFP clearly demonstrates that the mis-trafficked mutant channel accumulates in the intravesicular space of PI4K2A GFP -positive vesicles (Fig 3N-3S) . These results suggest that KCNC3 R423H is retained in the interior of anterograde or endosomal vesicles rather than being incorporated into the vesicular membrane.
As an integral membrane protein, N-glycans are added to the nascent KCNC3 protein in the ER with trimming of the oligosaccharide precursor, a critical quality-control measure for proper glycoprotein folding and vesicular trafficking through the Golgi en route to the plasma membrane. The expression of human KCNC3 R423H in CHO (Fig 3T) or U87 cells (Fig 3U) demonstrates altered glycosylation patterns consistent with our previous studies on KCNC3 R420H [19] .
As a voltage-dependent potassium channel, KCNC3/Kv3.3 displays high activation thresholds with fast activation and deactivation kinetics, conveying the property of sustained trains of high-frequency action potentials in neurons expressing them [40] . To assess the functional consequences of the KCNC3 R423H mutation, we performed electrophysiology in CHO cells transiently expressing the human KCNC3 WT or KCNC3 R423H channels. For KCNC3 WT , Fig  3V illustrates the slow inactivating outward current evoked during application of depolarizing voltage steps (increments of 10 mV from −80 mV to +70 mV). In contrast, cells expressing the KCNC3 R423H channels demonstrate the complete absence of current conductance by the mutant channel over the same voltage range (Fig 3W) , consistent with aberrant glycosylation and intracellular retention. ; and (N-P) a Golgi-endosome vesicle marker, PI4K2A
GFP with KCNC3 . (N) Boxed area is magnified in (Q-S), with inset in S clearly demonstrating intravesicular retention of KCNC3 . , resulting in a more severe eye phenotype entirely lacking ommatidia (Fig 4B compared to Fig 4A) . Moreover, simultaneous expression of exogenous KCNC3
WT with KCNC3 R423H did not overcome the eye phenotype (Fig 4C compared to   Fig 4A) , which implicates the dominant nature of the R423H allele. Similarly, KCNC3
R423H
self-cross, driven by dpp-Gal4 in the wing, led to disruption of veins L2, L3, and ACV in the wing (Fig 4E compared to Fig 4D) , whereas co-expression of KCNC3 WT with KCNC3 R423H resulted in a phenotype similar to KCNC3 R423H alone (Fig 4F compared to Fig 4D) . Studies in the eye and wing thus support the strong dominant negative effects exerted by KCNC3
. KCNC3 functions as a tetrameric voltage-gated potassium channel [41, 42] . This disease presents as an autosomal dominant phenotype, [7, 32] presumably resulting from the formation of a heterotetramer composed of WT and mutant monomers. We have determined the probabilities of heterotetramer interactions based on WT:423 ratios of 1:1 to 6:1 (S4A and S4B  Fig) [43] . These results are not supported by our data [19] (Fig 3A-3S) , which demonstrate that neither mutation is appreciably trafficked to the plasma membrane. To address the mechanism underlying the dominant phenotypic effects of KCNC3
, we also used differentially C-terminally labeled mutant and WT channels to explore intracellular trafficking and tetrameric protein association. KCNC3
WT-Clover was coexpressed with KCNC3 R423H-mRuby2 in cells at ratios from 1:1 to 6:1 and visualized by confocal microscopy (Fig 5D-5S ). As expected, KCNC3 WT-Clover alone traffics normally to the plasma membrane (Fig 5D) , whereas KCNC3 R423H-mRuby2 alone displays complete retention in intracellular vesicles (Fig 5G) . Co-expression with increasing ratios of KCNC3 WT : KCNC3
demonstrates complete co-localization (Fig 5H-5S ) suggestive of tetrameric co-assembly, along with complete retention of the KCNC3 WT protein in the same intracellular vesicles even at a ratio of 6:1 (Fig 5Q-5S) .
dEgfr rescues the Drosophila KCNC3 R423H eye phenotype
To identify the Drosophila pathway(s) affected by KCNC3
, we evaluated modifiers of the mutant phenotypes upon co-expression with a series of eye and wing specific determinants, including dEgfr, Ras, Rolled (mitogen-activated protein kinase [MAPK] ) and Notch [44] [45] [46] (S2 Table) . Effects of Egfr overexpression (UAS-Egfr.B) [47] were evaluated on a gmr-Gal4 (Fig 6A and 6B) or gmr-Gal4, UAS-KCNC3 R423H background (Fig 6C and 6D) [48, 49] . The MF then travels anteriorly, where Notch signaling establishes specification of the initial R8 photoreceptor neurons as the founding cells of the developing ommatidia. Signaling from the Egfr pathway leads to the recruitment of the remaining photoreceptor cells in a pairwise manner (R2/5, R3/4, R1/ 6, and finally R7), along with non-neuronal cone and pigment cells [46] . Therefore, we also evaluated the effects of Notch overexpression and found no effect on the KCNC3 R423H eye phenotype (S7D and S7H Fig) , further supporting specificity for the interaction of the mutant potassium channel allele with Egfr. The connection with EGFR was further corroborated with experiments in the wing demonstrating that co-expression of Egfr-RNAi and KCNC3 Pathological mechanisms associated with a congenital non-progressive SCA13 causative mutation causes more significant abnormalities in wing vein development than either strain alone ( Fig  6E-6G) . These results thus provide evidence that the developmental effects of KCNC3 R423H expression may be mediated through disruption of EGFR signaling.
KCNC3 R423H allele contributes to aberrant trafficking of EGFR
To test whether the potassium channel directly interacts with EGFR in mammalian cells, we transiently transfected U87 cells, known to express EGFR [50] , with either human KCNC3 WT or KCNC3
R423H
.Cellular lysates were subjected to immunoprecipitation with EGFR-specific antibodies. As expected, U87 cells expressed EGFR (Fig 7A, left panel) , while immunoblot analyses of the identical immunoprecipitation lysates showed no detectable bands in either the KCNC3 WT or KCNC3 R423H transfected cells (Fig 7A, right panel) , despite clear overexpression of KCNC3 (Fig 7B) . With no apparent direct protein-protein interaction, we examined the potential influence of aberrant KCNC3 R423H cellular trafficking on EGFR transit through the ER/Golgi to the plasma WT-Clover (n = 7) or KCNC3 R423H-Clover (n = 5) and in those expressing both KCNC3
WT-Clover : KCNC3 R423H-mRuby2 (1:1) constructs (n = 6). Current density was calculated by dividing the peak current evoked by a step from −70 to +70 mV by cell capacitance. Values are shown as mean±SEM, and significance was tested using a one-way ANOVA. Pathological mechanisms associated with a congenital non-progressive SCA13 causative mutation WT-mCerulean3 or KCNC3 R423H-mCerulean3 and with varying concentrations of a Citrine-tagged human EGFR [51] construct, using KCNC3: EGFR molar ratios from 5:1 to 1:1 (Fig 7C-7Q) . Representative confocal Z-stacks of cells expressing both KCNC3 WT and EGFR (Fig 7C-7E) illustrate that, despite an excess of KCNC3 WT (5:1), both proteins trafficked normally to the plasma membrane. Conversely, coexpression of KCNC3 R423H and EGFR at ratios of 5:1 (Fig 7F-7H ) and 4:1 (Fig 7I-7K ) reproducibly led to aberrant trafficking of EGFR with sequestration in intracellular vesicles that co-register with KCNC3 R423H (Fig 7H and 7K) . As the molar ratio of KCNC3
:EGFR is decreased to 2:1 (Fig 7L-7N) , EGFR is found both intracellularly sequestered and at the plasma membrane. At a ratio of 1:1, EGFR traffics normally to the plasma membrane, while in some cells the receptor continues to intracellularly co-register with KCNC3 R423H (Fig 7O-7Q) . The Together with the rescue of the Drosophila eye phenotype (Fig 6E and 6G ), these observations strongly implicate a specific link between this causative mutant allele and EGFR.
Discussion
Previous studies [43, 53, 54] identified KCNC3 R423H by screening index ataxia patients from US [15] and European [14, 16] DNA repositories. Our analysis of four pedigrees (3 US, 1 Swedish) unequivocally demonstrates SCA13 causation for this allele. The unifying endophenotype includes infantile onset, non-progressive cerebellar hypoplasia, lifetime improvement of motor and cognitive function, bradyphrenia, dysarthria, tremor, and the classic SCA feature of limb, truncal, and gait ataxia (S3 and S4 Tables). A striking clinical observation is the timeand activity-dependent improvement in motor and cognitive function, despite severe congenital cerebellar hypoplasia (Fig 1) .
To address this unique clinical pathology, we have developed fly and cellular models to investigate the underlying developmental, cellular, and biochemical events illuminating mechanisms of neurodevelopmental onset and dominant inheritance. Without SCA13 autopsy specimens, our current understanding of human pathology derives from clinical history and MRI-based cerebellar hypoplasia.
Drosophila eye differentiation has previously been used to model alleles causative in SCAs [23, [55] [56] [57] [58] . Consistent with neurodegeneration, all these mutant alleles display large, :human EGFR Citrine (1:1 ratio) also demonstrating membrane and intracellular trafficking for EGFR with continued intracellular retention for KCNC3 R423H . The total amount of DNA used in the co-transfection experiments was kept constant across ratios by adding control plasmid pcDNA 3.1.
https://doi.org/10.1371/journal.pone.0173565.g007
Pathological mechanisms associated with a congenital non-progressive SCA13 causative mutation disorganized eyes or a "rough eye" phenotype. In contrast, overexpression of human KCNC3 R423H in adult flies results in small, maldeveloped eyes exhibiting fused and disorganized ommatidia and disordered eye bristles, along with aberrant wing veins and shrunken wing formation, which suggests a neurodevelopmental effect. Consistent with a congenital phenotype, expression of KCNC3 R423H in third instar larvae caused disturbed patterning and fusion of ommatidial clusters, axonal bundle thinning, and reduced photoreceptor cell clusters. Collectively, these data support the neurodevelopmental nature of KCNC3 R423H in SCA13
patients.
Normal trafficking of plasma membrane-targeted proteins involves glycosylation and folding in the ER compartment believed to be followed by vesicular transport to the Golgi for glycan trimming and protein sorting [59] . Vesicles originating at the trans-Golgi network are involved in anterograde transport to the plasma membrane through close association with microtubules and actin filaments [60] [61] [62] data are further supported with biophysical data showing that <20% current conductance is detectable at a 1:1 ratio of WT:R423H. Collectively, these data form a strong basis for dominant inheritance but do not address the neurodevelopmental phenotype. The Egfr and Notch morphogenetic pathways are prominent pathways involved in Drosophila eye and wing development [46, 63, 64] . dEgfr is required for recruitment of neuronal and non-neuronal cells in the ommatidium [29, 65] . Because the profound KCNC3 R423H eye phenotype can be almost completely rescued by elevated Egfr expression and R423H/EgfrRNAi co-expression accentuates wing malformations, a direct or indirect association is strongly implicated between KCNC3 and Egfr, as well as a link between this potent growth factor receptor and cerebellar hypoplasia. Consistent with the fly data, co-expression of EGFR with KCNC3 R423H in mammalian cells leads to aberrant intracellular retention of EGFR that co-registers in vesicles with the mutant channel, the same anterograde and/or endosomal vesicles positive for PI4K2A. Normal EGFR plasma membrane localization is overcome only with a decrease in the concentration of the mutant channel below a ratio of 1:1. Negative co-immunoprecipitation data confirms that the intracellular retention of EGFR by KCNC3 R423H is not likely to be dependent on a direct protein-to-protein interactions. Therefore, our current hypothesis involves the intracellular sequestration of EGFR through yet unknown effects of KCNC3 R423H in anterograde or endosomal vesicles during cerebellar development. This hypothesis can be rationalized in part by previous studies in rats proving the presence of EGFR in Purkinje cells during late cerebellar development [66, 67] . It is also relevant to note that PI4K2A has been shown to co-localize with protein markers of the late endosome and is required for endocytic trafficking and degradation and/or downregulation of EGFR [68] .
Future studies to address the interplay of KCNC3 R423H , EGFR, and PI4K2A will provide important insights into the mechanisms governing normal cerebellar development and cerebellar hypoplasia in SCA13.
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